Search research articles
Contact Us
Filters
Showing results (241-250 of 636) with videos related to
Page
of 64
Sort By:
Journal of Virology
|
February 27, 2001
Internal ribosome entry site regulates translation of Kaposi's sarcoma-associated herpesvirus FLICE inhibitory protein
W Low, M Harries, H Ye, et al.
Histopathology
|
August 31, 2007
Chondroblastomas but not chondromyxoid fibromas express cytokeratins: an unusual presentation of a chondroblastoma in the metaphyseal cortex of the tibia
K Bousdras, P O'Donnell, S Vujovic, et al.
Journal of Biomolecular Screening
|
June 16, 2009
Dequalinium, a new inhibitor of Mycobacterium tuberculosis mycothiol ligase identified by high-throughput screening
Maria-Teresa Gutierrez-Lugo, Heather Baker, Joseph Shiloach, et al.
Frontiers in Cellular and Infection Microbiology
|
April 1, 2021
Tuberculosis Drug Discovery: A Decade of Hit Assessment for Defined Targets
Sangmi Oh, Lena Trifonov, Veena D Yadav, et al.
The Journal of Organic Chemistry
|
April 29, 2015
Investigation and conformational analysis of fluorinated nucleoside antibiotics targeting siderophore biosynthesis
Surendra Dawadi, Kishore Viswanathan, Helena I Boshoff, et al.
Lancet (London, England)
|
October 15, 1994
Treatment of good-risk, stage II, non-seminomatous testis cancer
C Boshoff, G Rustin, R Begent, et al.
ACS Medicinal Chemistry Letters
|
April 20, 2018
Conformationally Constrained Cinnolinone Nucleoside Analogues as Siderophore Biosynthesis Inhibitors for Tuberculosis
Surendra Dawadi, Helena I M Boshoff, Sae Woong Park, et al.
Psychological Reports
|
December 13, 2006
Testing antecedents to sales performance in postapartheid era: a field study
John E Barbuto, Liezel Barbuto, Piet De La Rey, et al.
Chemmedchem
|
March 20, 2015
Novel 1,4-substituted-1,2,3-triazoles as antitubercular agents
Jarrad M Altimari, Samantha C Hockey, Helena I Boshoff, et al.
Molecular Cancer Therapeutics
|
January 14, 2009
Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets
James M Flanagan, Juan M Funes, Stephen Henderson, et al.
Page
of 64
Search research articles
Search
Showing results (241-250 of 636) with videos related to
Sort By:
Page
of 64
Journal of Virology
|
February 27, 2001
Internal ribosome entry site regulates translation of Kaposi's sarcoma-associated herpesvirus FLICE inhibitory protein
W Low, M Harries, H Ye, et al.
Histopathology
|
August 31, 2007
Chondroblastomas but not chondromyxoid fibromas express cytokeratins: an unusual presentation of a chondroblastoma in the metaphyseal cortex of the tibia
K Bousdras, P O'Donnell, S Vujovic, et al.
Journal of Biomolecular Screening
|
June 16, 2009
Dequalinium, a new inhibitor of Mycobacterium tuberculosis mycothiol ligase identified by high-throughput screening
Maria-Teresa Gutierrez-Lugo, Heather Baker, Joseph Shiloach, et al.
Frontiers in Cellular and Infection Microbiology
|
April 1, 2021
Tuberculosis Drug Discovery: A Decade of Hit Assessment for Defined Targets
Sangmi Oh, Lena Trifonov, Veena D Yadav, et al.
The Journal of Organic Chemistry
|
April 29, 2015
Investigation and conformational analysis of fluorinated nucleoside antibiotics targeting siderophore biosynthesis
Surendra Dawadi, Kishore Viswanathan, Helena I Boshoff, et al.
Lancet (London, England)
|
October 15, 1994
Treatment of good-risk, stage II, non-seminomatous testis cancer
C Boshoff, G Rustin, R Begent, et al.
ACS Medicinal Chemistry Letters
|
April 20, 2018
Conformationally Constrained Cinnolinone Nucleoside Analogues as Siderophore Biosynthesis Inhibitors for Tuberculosis
Surendra Dawadi, Helena I M Boshoff, Sae Woong Park, et al.
Psychological Reports
|
December 13, 2006
Testing antecedents to sales performance in postapartheid era: a field study
John E Barbuto, Liezel Barbuto, Piet De La Rey, et al.
Chemmedchem
|
March 20, 2015
Novel 1,4-substituted-1,2,3-triazoles as antitubercular agents
Jarrad M Altimari, Samantha C Hockey, Helena I Boshoff, et al.
Molecular Cancer Therapeutics
|
January 14, 2009
Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets
James M Flanagan, Juan M Funes, Stephen Henderson, et al.
Page
of 64